Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of British Columbia

$27,000.00

Investigating the Utility of Urinary Cytokines and Metabolite Profiles in Predicting Treatment Response to Early and Late Acute T-cell Mediated Rejection

EF 2025-26

Résumé
Organ rejection is a major cause of kidney transplant failure. Acute rejection occurs when certain cells of the immune system start to attack the transplanted organ. Standard treatment uses medication that targets these immune cells that cause acute rejection. But even with standard treatment, rejection can persist and this may be from chronic types of rejection that are also present. A better understanding of what will work in each situation is essential to develop appropriate treatment and prevent kidney damage from rejection. Cytokines and metabolites are molecules related to the immune system. They can be detected in the urine and tell us what is happening to the kidney. We want to see if these molecules can predict whether children with kidney rejection will get better with the usual treatment. We will find out how these cytokine and metabolite patterns relate to early and later (chronic) forms of rejection, and response to treatment. And we will see whether treatment response prediction can be improved by including clinical information on top of cytokine and metabolite patterns. We will analyze urine samples collected at the time of kidney biopsies from children with kidney transplants. We will use modern analysis tools to look for differences in cytokine levels and metabolites profiles based on treatment response and signs of chronic rejection. This information will be used with other clinical information to develop prediction algorithms that could be used in the clinic to make better decisions about rejection treatment. If we can understand how to predict treatment response, we can use the right medicine from the start. This way, we could reduce how long the rejection lasts and improve the survival of the transplanted organ.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
572776
Name
Ly Phillip
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the Utility of Urinary Cytokines and Metabolite Profiles in Predicting Treatment Response to Early and Late Acute T-cell Mediated Rejection
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Acute T Cell-Mediated Rejection; Cxcl10; Cytokines; Early And Late Rejection; Il-6; Metabolomics; Pediatric Kidney Transplantation; Predicting Treatment Response; Solid Organ Transplant
Abstract
Organ rejection is a major cause of kidney transplant failure. Acute rejection occurs when certain cells of the immune system start to attack the transplanted organ. Standard treatment uses medication that targets these immune cells that cause acute rejection. But even with standard treatment, rejection can persist and this may be from chronic types of rejection that are also present. A better understanding of what will work in each situation is essential to develop appropriate treatment and prevent kidney damage from rejection. Cytokines and metabolites are molecules related to the immune system. They can be detected in the urine and tell us what is happening to the kidney. We want to see if these molecules can predict whether children with kidney rejection will get better with the usual treatment. We will find out how these cytokine and metabolite patterns relate to early and later (chronic) forms of rejection, and response to treatment. And we will see whether treatment response prediction can be improved by including clinical information on top of cytokine and metabolite patterns. We will analyze urine samples collected at the time of kidney biopsies from children with kidney transplants. We will use modern analysis tools to look for differences in cytokine levels and metabolites profiles based on treatment response and signs of chronic rejection. This information will be used with other clinical information to develop prediction algorithms that could be used in the clinic to make better decisions about rejection treatment. If we can understand how to predict treatment response, we can use the right medicine from the start. This way, we could reduce how long the rejection lasts and improve the survival of the transplanted organ.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ly, Phillip
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~